2024-09-02 18:08:00
They discovered a treatment for incurable prostate cancer
Researchers from Flinders University and the University of South Australia have revealed a promising new technique that can be used to treat the most aggressive types of prostate cancer. Their research explores the role of a new drug, CDKI-73, in treating drug-resistant prostate cancer that resists conventional treatments.
The study, published in the British Journal of Cancer and led by Associate Professor Luke Selth of Flinders University and Professor Shudong Wang of the University of South Australia, investigated the potential of a protein concentration called cyclin-dependent kinase 9 (CDK9), which plays an important role in the growth and survival of prostate cancer cells. More importantly, the researchers tested whether the CDK9 inhibitor, CDKI-73, could overcome cancer resistance to current treatments.
Using advanced technologies, the study examined the effects of CDKI-73 using various prostate cancer models, including patient tumor samples, revealing not only the effect of the inhibitor but also providing new insights into your status.
CDKI-73 is currently being investigated in Phase 2 clinical trials in patients with relapsed and refractory acute myeloid leukemia, an aggressive blood cancer.
#discovered #treatment #incurable #prostate #cancer